Funder
The Bill and Kathleen Troost Innovation Grant of the Canadian Cancer Society
University of Toronto Fellowship
Lorne F. Lambier, Q.C. Scholarship
OSOTF Studentship at Mount Sinai Hospital
Paul Starita Graduate Student Fellowship
Research Training Centre Travel Award at Mount Sinai Hospital
Laboratory Medicine and Pathobiology (LMP) Travel Award at the University of Toronto
Ontario Graduate Scholarship – Faculty of Medicine at University of Toronto
Scace Graduate Fellowship in Prostate Cancer Research
George Sidney Brett Memorial Fund
Frank Fletcher Memorial Fund
Research Training Centre (RTC) Travel Award at Mount Sinai Hospital
Publisher
Springer Science and Business Media LLC
Subject
Genetics (clinical),Developmental Biology,Genetics,Molecular Biology
Reference59 articles.
1. Van Vlodrop IJ, Niessen HE, Derks S, Baldewijns MM, van Criekinge W, Herman JG, et al. Analysis of promoter CpG island hypermethylation in cancer: location, location, location! Clin Cancer Res. 2011. doi: 10.1158/1078-0432.CCR-10-3394 .
2. Esteller M. CpG island hypermethylation and tumor suppressor genes: a booming present, a brighter future. Oncogene. 2002;21(35):5427–40.
3. Sproul D, Kitchen RR, Nestor CE, Dixon JM, Sims AH, Harrison DJ, et al. Tissue of origin determines cancer-associated CpG island promoter hypermethylation patterns. Genome Biol. 2012. doi: 10.1186/gb-2012-13-10-r84 .
4. Esteller M, Herman JG. Cancer as an epigenetic disease: DNA methylation and chromatin alterations in human tumours. J Pathol. 2002;196(1):1–7.
5. Vilain A, Vogt N, Dutrillaux B, Malfoy B. DNA methylation and chromosome instability in breast cancer cell lines. FEBS Lett. 1999;460(2):231–4.